Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Assessing Novavax (NVAX) Valuation After Strong 2025 Results And Return To Profitability
Novavax (NASDAQ:NVAX) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
How Investors Are Reacting To Novavax (NVAX) Swinging From Losses To Profits On Vaccine Revenue
Assessing Novavax (NVAX) Valuation After Strong Earnings Beat And Return To Profitability
Novavax Inc (NVAX) - Insider Monkey
Novavax, Inc. $NVAX Stock Position Lowered by Vanguard Group Inc. - Daily Political
Earnings: Novavax lifts 2026 revenue outlook on vaccine deals, eyes profitability by 2028, ETPharma
Novavax (NASDAQ:NVAX) Upgraded to Hold at Wall Street Zen - Daily Political
Novavax (NASDAQ:NVAX) Upgraded by Wall Street Zen to Hold Rating
Novavax Profit And Partnership Pivot Reframe Risk And Valuation Story
Novavax (NASDAQ:NVAX) Trading Down 9.8% - Here's What Happened
Novavax (NASDAQ:NVAX) Stock Price Down 9.8% - Time to Sell? - Stock Observer
Novavax Q4 Earnings Call Highlights | MarketBeat
Novavax (NASDAQ:NVAX) Releases Earnings Results, Beats Estimates By $0.77 EPS - Markets Daily
Novavax (NVAX) Turns Profitable With US$440 Million TTM Net Income Challenging Bearish Views
Novavax (NASDAQ:NVAX) Posts Quarterly Earnings Results, Beats Expectations By $0.77 EPS - Stock Observer
Novavax Q4 Earnings Call Highlights - Daily Political
Novavax to Participate in Upcoming Investor Conferences | Morningstar
Power Hour Surge: Quantum Breakouts, Biotech Visibility, and Crypto Strategy Running into the Close
Why Is Novavax (NVAX) Stock Soaring Today
Novavax Sees Unusually High Options Volume (NASDAQ:NVAX)
Novavax (NASDAQ:NVAX) Sets New 52-Week High on Earnings Beat
Novavax (NASDAQ:NVAX) Reaches New 1-Year High After Earnings Beat - Daily Political
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Mixed Long Term Returns
Jupiter Asset Management Ltd. Sells 779,802 Shares of Novavax, Inc. $NVAX
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Brokerages
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Novavax (NASDAQ:NVAX) Stock Passes Above 200 Day Moving Average - Time to Sell? - Daily Political
Novavax (NASDAQ:NVAX) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?
Assessing Novavax (NVAX) Valuation After Recent Share Price Momentum And Partnership Shifts
Novavax (NVAX) Is Up 5.5% After Easing Inflation Boosts Interest In Protein-Based Vaccines
Novavax News
Adani Total Gas stock (ATGL) surged 37% in two days: What's going on with gas prices?
Starbucks (SBUX) shares analysis: Is Starbucks a good stock to buy right now?
Will Nvidia (NVDA) stock hit $300: What is the NVDA price prediction for 2030?
How to buy the top AI stocks in the Emirates: Microsoft (MSFT), Nvidia (NVDA), Alphabet stock
Most active stocks analysis: NVIDIA (NVDA), Tesla (TSLA), Amazon (AMZN) stock
Latest news
Show moreApple to Lower App Store Commission Fees in China: Strategic Move for Developer Ecosystem Growth
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation
